Chief Physician, Department of Breast Medicine, Peking University Cancer Hospital, MD. Graduated from the Clinical Medicine Program of Peking University People's Hospital in 2005. He has been working in the Department of Breast Medicine, Peking University School of Oncology ever since graduation. He has long‑term engagement in the medical treatment of breast cancer, with extensive clinical experience particularly in post‑operative breast cancer and recurrent and metastatic breast cancer. He completed a short‑term visiting fellowship at the National Cancer Center in Tokyo, Japan in 2011, and pursued further study at the Curie Institute in France from 2016 to 2018, where he conducted translational medical research on breast cancer and published key papers. His main research interests and work focus lie in standardized and individualized therapies for advanced breast cancer, including chemotherapy, targeted therapy, endocrine therapy and immunotherapy. As a key co‑investigator, he has participated in dozens of international and domestic multi‑center clinical trials for advanced breast cancer. He has published more than twenty papers in core journals and SCI‑indexed journals, presided over one project funded by the Beijing Natural Science Foundation, taken part in multiple ministerial and municipal research projects, and contributed to the compilation of several monographs on oncology.